KCNJ4 and lung cancer: In small cell lung cancer (SCLC), KCNJ4 modulates cell growth, and its silencing sensitizes lung cancer cell lines to the cytotoxic effects of adriamycin, cisplatin, and etoposide (Table 2) [134].